Faculty Opinions recommendation of Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.

2017 ◽  
Author(s):  
Katherine Fuh
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
High Grade ◽  
Serous Ovarian Cancer

In vivo synergism between PARP-inhibitor olaparib and HSP90-inhibitor AT13387 in high grade serous ovarian cancer patient derived xenografts.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e17045-e17045 ◽  
Author(s):  
Panagiotis Konstantinopoulos ◽  
Sangeetha Palakurthi ◽  
Qing Zeng ◽  
Shan Zhou ◽  
Joyce F. Liu ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
Parp Inhibitor ◽  
Hsp90 Inhibitor ◽  
High Grade ◽  
Serous Ovarian Cancer

scholarly journals Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples

2021 ◽  
Author(s):  
Claire R. Morden ◽  
Ally C. Farrell ◽  
Mirka Sliwowski ◽  
Zelda Lichtensztejn ◽  
Alon D. Altman ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
Chromosome Instability ◽  
High Grade ◽  
Serous Ovarian Cancer

scholarly journals Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts

2014 ◽  
Vol 8 (3) ◽  
pp. 656-668 ◽  
Author(s):  
Monique D. Topp ◽  
Lynne Hartley ◽  
Michele Cook ◽  
Valerie Heong ◽  
Emma Boehm ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
High Grade ◽  
Serous Ovarian Cancer

scholarly journals Two different, mutually exclusively distributed,TP53mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?

2017 ◽  
Vol 3 (4) ◽  
pp. a001461 ◽  
Author(s):  
Nyamdelger Sukhbaatar ◽  
Anna Bachmayr-Heyda ◽  
Katharina Auer ◽  
Stefanie Aust ◽  
Simon Deycmar ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
Serous Ovarian Cancer ◽  
Peritoneal Tumor ◽  
Tumor Tissues ◽  
Tumor Origin

scholarly journals Heterogeneous alteration of the ERBB3–MYC axis associated with MEK inhibitor resistance in a KRAS-mutated low-grade serous ovarian cancer patient

2019 ◽  
Vol 5 (6) ◽  
pp. a004341 ◽  
Author(s):  
Ilaria Colombo ◽  
Swati Garg ◽  
Arnavaz Danesh ◽  
Jeffrey Bruce ◽  
Patricia Shaw ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
Mek Inhibitor ◽  
Low Grade ◽  
Serous Ovarian Cancer ◽  
Inhibitor Resistance
Sign in / Sign up

Export Citation Format

Share Document